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Preface: 
 
This PhD project is based on studies conducted between 2004 and 2006 at Center for 
Sensory Motor Interaction, Aalborg Denmark. Study III was written as a joint 
collaboration between human findings (SMI) and animal findings. The animal findings 
were solely carried out in Nagoya, Japan whilst human studies were solely performed in 
Aalborg, Denmark. 
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 1 
 Introduction 
Musculoskeletal pain is widely prevalent (Urwin et al. 1998;Picavet and Hazes 
2003;Salaffi et al. 2005) and is the most common cause of non-malignant pain in the 
general population (Katz 2002). The prevalence of musculoskeletal pain complaints 
within various populations ranges between  40% and  66% (Taylor 2005;Zapata et al. 
2006) while selected samples can have a prevalence as high as 88% (Eriksen 2003). This 
represents a major burden to society in terms of pain/morbidity and associated healthcare 
costs (Yelin 2003). 
 
The musculotendinous unit accounts for a significant portion of the musculoskeletal pain 
reported in the literature. Muscle pain as an entity is common with findings of 30% 
prevalence in a general practice population and 15% prevalence among factory sewing 
machine operators (Skootsky et al. 1989;Kaergaard and Andersen 2000). Tendon pain in 
the form of tendinopathy is a common, painful and frequently disabling (Khan and Cook 
2003) subset within the body of musculoskeletal complaints. The prevalence of 
‘tendonitis’ is reported between 3% and 19% (Salaffi et al. 2005;Forde et al. 2005;Kaplan 
et al. 2005) depending on the characteristics of the sample population. Thus, pain in the 
musculotendinous unit represents a significant clinical problem and as such deserves 
detailed investigation. 
 
Clinical Background 
Clinically, muscle pain is a frequent complaint of those suffering from myofascial pain 
syndromes (Carlson et al. 1993;Shah et al. 2005), fibromyalgia (Wolfe et al. 1990;Staud 
2006a) and neck pain syndromes such as work related  trapezius myalgia (Larsson et al. 
2004;Rosendal et al. 2004;Sandberg et al. 2005). Common findings in muscle biopsies 
obtained from fibromyalgia and trapezius myalgia subjects include moth eaten fibres, 
changes in perfusion cross sectional area (Kadi et al. 1998a;Kadi et al. 1998b;Larsson et 
al. 2004) and increased DNA fragmentation (Sprott et al. 2004). Palpable taut bands in 
canine muscle (comparable to human myofascial trigger points) have been shown to 
display enlarged ‘knot-like’ fibres (Simons and Stolov 1976). In addition to these 
structural changes, local release of endogenous sensitising substances has been 
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demonstrated, with increased intramuscular, interstitial substance P and inflammatory 
infiltrates shown in fibromyalgia (Bengtsson et al. 1986;Sprott et al. 1998); increased 
interstitial levels of glutamate, lactate, pyruvate and serotonin in trapezius myalgia 
(Rosendal et al. 2004)and increased levels of bradykinin, serotonin and protons in 
myofascial pain subjects (Shah et al. 2005). This release is thought to result in peripheral 
sensitisation of nociceptors and ultimately to the perception of pain. Muscle nociceptors 
are known to exist in and around connective tissue and small arterioles (Reinert et al. 
1998). The likely distribution of sites of nociceptive activity within different muscle 
structures following endogenous sensitisation is at present not known; indeed, relative 
sensitivity/afferent fibre population density in differing muscle structures has not been 
fully investigated. Whether, and to what intensity (as a reflection of afferent density) this 
nociceptive activity occurs in deep muscle afferents or in other structures such as the 
tissue of the fascia/epimysium or tendinous tissues may be important in terms of targeting 
therapy. 
 
Clinical tendinopathy and resultant pain is not fully understood. Essentially, tendinopathy 
can be seen as a maladaptive response to external stresses (Leadbetter 1992). Eccentric or 
muscle lengthening activities are thought to be particularly damaging to tendon tissue and 
are strongly implicated in the development of tendinopathy (Lieber et al. 1997;Paavola et 
al. 2002;Sharma and Maffulli 2005). The classic structural changes seen in tendinopathy 
are increased ground substance, neovascularisation, collagen disruption and 
hypercellularity (fibroblastic proliferation: tendinopathy is not an inflammatory process) 
in the body of the affected tendon (Astrom and Rausing 1995;Kraushaar and Nirschl 
1999;Rolf et al. 2001;Alfredson and Lorentzon 2002). Pain in tendons seems to be a 
result of these changes. It has been proposed that in particular, the neovascularisation is 
strongly associated with pain (Alfredson et al. 2003) such that sclerosing these vessels 
provides pain relief (Ohberg and Alfredson 2003;Alfredson and Ohberg 2005b). Again, 
as per muscle pain, it is likely that clinical tendon pain is a result of sensitisation of 
nociceptors via release of endogenous algesic substances. In line with this idea, 
microdialysis of tendinopathic tissue displays significant increases in glutamate and 
lactate (Alfredson et al. 2002;Alfredson and Lorentzon 2002) compared to healthy tendon 
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tissue. Recently, substance P (SP) and calcitonin gene-related peptide (CGRP) afferent 
immunoreactivity has been demonstrated at the tendon-bone/origin of tendons (Ljung et 
al. 2004). In addition, structural adaptation at the tendon-bone level has been suggested in 
lateral elbow tendinopathy (Edelson et al. 2001). This would imply that sensitivity of, and 
nociceptive activity in, the tendon bone-junction may be important in some 
tendinopathies. There is no current information regarding relative sensitivities between 
tendon and tendon-bone junction or as mentioned previously, muscle tissue. 
 
Many studies have examined aspects of sensory manifestations in people experiencing 
muscle pain and to a very much lesser extent tendon pain. Clinical muscle pain is often 
associated with somatosensory changes such as increased mechanosensitivity 
(mechanical hyperalgesia) (Ohrbach and Gale 1989;Sandberg et al. 2005) and altered 
sensitivity to light touch (allodynia) (Leffler et al. 2003). Similarly, clinical tendinopathy 
is associated with increased mechanical sensitivity in the affected tendons (Astrom and 
Westlin 1992;Wright et al. 1992;Wright et al. 1994;Maffulli et al. 2003;Fredberg et al. 
2004;Slater et al. 2005). Referral or spread of pain is frequently seen with clinical muscle 
pain (Vecchiet et al. 1991;Hong 1996;Hong C-Z 1998;Meyer 2002;Broadhurst et al. 
2004;Al-Shenqiti and Oldham 2005;Fernandez-de-Las-Penas et al. 2006) but is largely 
unexplored for clinical tendon pain (Slater et al. 2005). Referred pain can be induced in 
anaesthetised (Laursen et al. 1999) limbs indicating that central pain processing 
mechanisms are involved in the perception of referred pain and central mechanisms are 
known to be involved in chronic pain maintenance/generation (Graven-Nielsen et al. 
2000;Arendt-Nielsen and Graven-Nielsen 2003;Sarlani et al. 2004;Staud 2006b). 
Therefore investigating referred pain mechanisms may provide insight into relevant pain 
processing mechanisms in tendinopathy and muscle/fascia pain. It may also add to the 
body of knowledge regarding assessment and diagnosis of tissue injury/dysfunction based 
on likely referred pain patterns. 
  
Investigative techniques 
Social, motivational, cognitive and emotional factors are important aspects of a 
subjective clinical pain experience (Sullivan et al. 1998;Moseley 2004;Sullivan et al. 
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2005;Lame et al. 2005). These factors are not controllable in clinical settings and  may be 
a considerable source of confounding error in the investigation of basic pain mechanisms 
involved in musculoskeletal pain complaints (Arendt-Nielsen and Svensson 2001).  
 
Experimental pain research circumvents this problem by inducing a transient pain 
experience in healthy subjects and assessing the associated sensory manifestations. This 
technique has been frequently used to assess nociceptive characteristics and sensory-
motor manifestations in muscle tissue (Kellgren J.H. 1938;Jensen and Norup 
1992;Simone et al. 1994;Svensson et al. 1995;Arendt-Nielsen et al. 1997;Baker et al. 
1997;Graven-Nielsen et al. 1997a;Graven-Nielsen et al. 1997b;Graven-Nielsen et al. 
1997c;Graven-Nielsen et al. 1997d;Graven-Nielsen et al. 1998;Babenko et al. 2000;Bajaj 
et al. 2000;Barlas et al. 2000;Witting et al. 2000;Slater et al. 2003;Wang et al. 2004) 
providing valuable insights into muscle pain mechanisms and ultimately it is hoped 
toward a better understanding of clinical muscle pain. However, most of this investigative 
work has not discriminated between different structural components (muscle, tendon, 
tendon-bone junction and fascia/connective tissue) of the musculotendinous unit. As 
previously mentioned, muscle tissue is known to have a nociceptive innervation (Mense 
1993) and it has been established that fascial and tendon tissue are also supplied with 
nociceptive afferent fibres (Stillwell D 1957;Yahia et al. 1992;Bjur et al. 2005;Danielson 
et al. 2006). Fascial tissue has not been comprehensively investigated and might well be a 
rich source of nociceptive afferent activity during clinical and experimental muscle pain 
states. Similarly, tendon tissue pain mechanisms remain relatively unexplored compared 
to muscle tissue despite an obvious clinical relevance.  
 
A small number of studies have utilised experimental pain induction techniques directed 
toward fascial and/or tendinous tissues (Kellgren J.H. 1938;Inman and Saunders 
1944;Steinbrocker et al. 1953;Kawakita et al. 1991;Itoh and Kawakita 2002;Itoh et al. 
2004)  however these studies are of small sample size and do not yield comparative data 
regarding the muscle, tendinous structures and fascia. In order to fully understand clinical 
musculotendinous pain it is vital that in-depth knowledge of tissue sensitivity and 
therefore possible proportional contribution of each tissue type to the overall nociceptive 
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barrage be ascertained. It is important that the common sensory manifestations of clinical 
musculotendinous pain (mechanical hyperalgesia, referred pain) are assessed for each 
tissue type not only in control conditions, but also in sensitised conditions which may 
allow inferences to be made regarding tissue type and clinical pain states. Therefore, a 
detailed, comparative investigation in each tissue of sensory manifestations in response to 
standardised experimentally induced pain is required.  
 
Aims of PhD project 
This study aims to investigate the sensory manifestations to experimental pain induction 
in muscle, tendon, tendon-bone junction and fascial tissue in humans. This investigation 
shall quantify sensory manifestations often seen clinically and during experimental pain. 
Thus, pain sensitivity and mechanical sensitivity due to pain (assessment of hyperalgesic 
responses) and referred pain shall be the main focus areas of the study. This project will 
investigate these tissues under resting (control) and sensitised conditions (Fig. 1). 
 
 
Fig. 1: Schematic representation of PhD project investigating sensory manifestations of experimentally 
induced pain in muscle, tendon and fascial tissues in a control (resting) condition to establish basic 
nociceptive characteristics as well as under sensitised conditions to investigate changes to nociceptive 
mechanisms during sensitisation. Assessment procedures consisted of pain intensity, mechanical sensitivity 
to pressure and pain distribution recording (referred pain). 
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Induction
Condition
Assessment
Muscle (I,II,III) Tendon (I,II,IV)
Fascia (III) Tendon-bone (I,II)
Muscle (I,II,III) Tendon (I,II,IV)
Fascia (III) Tendon-bone (I,II)
Control: (I, II, III and IV) Sensitised: Delayed onset 
soreness (II and III)
Pain 
intensity
Mechanical 
sensitivity
Referred 
pain
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1: Nociception from deep tissues 
Nociceptive activity in animals and pain in humans from deep tissues is perceived 
following afferent activity in Aδ (group III) and C-fibres (group IV) (Weddell and 
Harpman 1940;Mense and Stahnke 1983;Mense and Meyer 1985). Group III fibres are 
thinly myelinated and are characterised as having conduction velocities of between 2.5 
and 30 m/s while group IV fibres are unmyelinated and have conduction velocities below 
2.5 m/s (Mense and Meyer 1985). Nociceptive afferents are seen in the tissues as free 
nerve endings (Stacey M.J. 1969) and typically, are defined as being activated only by 
noxious thermal, chemical or high mechanical threshold stimulation (Kumazawa and 
Mizumura 1977;Hoheisel et al. 2005). Slowly conducting afferent fibres (group III and 
IV) and nerve endings have been observed in animal tendon, fascial (Stillwell D 
1957;Andres et al. 1985;Mense and Meyer 1985) and muscle tissue (Stacey M.J. 1969). 
Histologically, sensory innervation and small fibre free nerve endings have been 
demonstrated in human fascial tissue (Weddell and Harpman 1940;Yahia et al. 1992) 
whilst intraneural microneurography observations in human muscle tissue (Marchettini et 
al. 1996) have identified putative nociceptive afferent activity. Substance P (SP) and 
calcitonin-gene related peptide (CGRP) immunoreactivity has been demonstrated in 
human tendon tissue (Bjur et al. 2005;Danielson et al. 2006) indicating a thin fibre 
sensory innervation (most likely serving a nociceptive function). In both tendon and 
muscle tissue, the nerve endings are mostly found in and around small arterioles and 
blood vessels in the tissue (Reinert et al. 1998;Bjur et al. 2005;Forsgren et al. 
2005;Danielson et al. 2006). Thus, the peripheral apparatus required for transduction and 
transmission of nociceptive stimuli is present in muscle, fascial and tendinous structures. 
 
Afferent activity from peripheral nociceptors is conveyed to the dorsal horn of the spinal 
cord, mainly to lamina I and III-V (Hoheisel et al. 1989;Todd et al. 2000). Thereafter, 
spinothalamic tract  fibres (mostly but not exclusively) convey this activity to higher 
centres such as the thalamus (Craig et al. 1994) and cortex (Coghill et al. 1994). This is a 
reciprocal process however as nociceptive activity can be facilitated or inhibited by a 
number of supraspinal structures and mechanisms utilising descending pathways 
(Gebhart 2004). 
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Following injury or disease, peripheral nociceptors can become sensitised. This 
sensitisation occurs secondary to the release of endogenous substances (eg. inflammatory 
cytokines, neurotrophins, serotonin, bradykinin, glutamate, protons, prostaglandins and 
substance P) which are released locally in response to injury/inflammation and can 
directly or in combination lead to sensitisation of nociceptors (Mense 1981;Berberich et 
al. 1988;Nakamura-Craig and Gill 1991;Mense 1993;Issberner et al. 1996;Cairns et al. 
2003a;Hoheisel et al. 2004;Hoheisel et al. 2005) with subsequent lowering of nociceptor 
response thresholds and often, increased background activity. This process likely explains 
the local tenderness, mechanical sensitivity and pain seen with injury or inflammatory 
conditions. In addition, this process can become self sustaining to an extent as local 
afferent activity can cause the antidromic release of substances such as SP and CGRP 
(Pedersen-Bjergaard et al. 1991;Loaiza et al. 2002) which may directly or indirectly lead 
to ongoing sensitisation. 
 
Sustained nociceptive peripheral activity may lead to the development of central 
sensitisation (Woolf and Salter 2000). The most well known manifestations of this 
process are long-lasting neuronal activity secondary to stimulus, increased response to 
sub and suprathreshold stimuli and neuronal receptive field expansion (Hoheisel et al. 
1993;Hoheisel et al. 1994). This central sensitisation mechanism probably accounts for 
the widespread pain and hyperalgesia/allodynia commonly seen in chronic pain patients 
in whom central sensitisation is thought to occur (Graven-Nielsen and Arendt-Nielsen 
2002). 
 
1.1 Clinical muscle, fascial and tendon pain 
Peripheral sensitisation of nociceptors likely plays a role in clinical muscle pain. 
Microdialysis measurement from muscles of subjects with and without  muscle pain 
demonstrate increased concentrations of potassium, serotonin, glutamate, bradykinin, SP, 
CGRP, cytokines and altered pH in muscle pain subjects (Rosendal et al. 2004;Shah et al. 
2005;Rosendal et al. 2005). Central sensitisation also seems to be associated with muscle 
pain. Fibromyalgia  (Staud 2006a) and myofascial pain syndrome patients frequently 
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complain of pain in the muscles and there is significant evidence for facilitated central 
pain processing mechanisms in people suffering with these conditions (Bendtsen et al. 
1996;Graven-Nielsen et al. 2000;Staud et al. 2001;Staud et al. 2003). However it is not 
possible to say what relevant contribution fascial and muscle afferent activities make to 
clinical pain. No studies have examined the contributions of each tissue to the pain state. 
 
Tendinopathy pain is associated with increased number and volume of blood vessels in 
the paratendinous tissue (Alfredson et al. 2003;Alfredson and Ohberg 2005b;Zeisig et al. 
2006). The walls of these blood vessels are supplied with a SP and CGRP 
immunoreactive sensory innervation (Danielson et al. 2006). Altered local biochemical 
composition may suggest peripheral sensitisation is an important factor in tendinopathy 
pain perception (Alfredson et al. 2000;Alfredson et al. 2001b). Central pain processes 
may be involved in tendon pain states (Slater et al. 2005), however there are very few 
studies and little hard data is available. 
 
 
1.2 Experimental pain techniques 
Experimental pain induction affords the opportunity to investigate sensory manifestations 
of pain in a controlled environment. Essentially it involves standardised activation of 
nociceptive afferents in deep tissues and subsequent measurement of the various 
parameters of interest. This section shall review means of nociceptor activation employed 
in experimental pain studies. 
 
1.2.1 Pain induction 
There are two broad divisions of deep tissue pain induction techniques: those that utilise 
externally introduced stimuli (exogenous) and those that utilise internal or natural stimuli 
(endogenous). For a detailed description of the range of these techniques see Graven-
Nielsen  (2006). 
 
Exogenous methods used to induce deep tissue pain are diverse ranging from mechanical 
stimulation (Kosek et al. 1996;Polianskis et al. 2002;Nie et al. 2005a) (studies  I to IV) to 
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electrical stimulation  (Kosek and Hansson 2002;Kosek and Hansson 2003;Koltzenburg 
et al. 2006) to injection of algogenic substances such as capsaicin (Sohn et al. 
2000;Arima et al. 2000;Witting et al. 2000;Wang et al. 2002) (study IV), glutamate 
(Cairns et al. 2001;Svensson et al. 2003;Cairns et al. 2003a;Cairns et al. 2003b;Ge et al. 
2005) (study IV), serotonin/bradykinin (Babenko et al. 1999a;Babenko et al. 
1999b;Babenko et al. 2000) and hypertonic saline (Kellgren J.H. 1938;Steinbrocker et al. 
1953;Graven-Nielsen et al. 1997b;Graven-Nielsen et al. 1997c;Graven-Nielsen et al. 
1997d;Graven-Nielsen et al. 1997e;Graven-Nielsen et al. 1998;Hodges et al. 
2003;Bennell et al. 2005) (studies I to IV). These techniques are useful as the tissue(s) of 
interest can be very specifically targeted. 
 
Endogenous methods of pain induction are less plentiful and chiefly amount to pain 
induced through exercise (particularly lengthening or eccentric exercise) and through 
exercise with ischaemia. Eccentric exercise is the most widely employed method of 
endogenous pain induction in humans. Following this type of exercise, delayed onset 
soreness (DOS) over the musculotendinous unit is present after 24-48 hours (Newham 
1988;Whitehead et al. 2001) allowing investigation of pain manifestations to be 
undertaken in this period. The site of nociceptive activity during DOS while thought to 
reside within the exercised muscle has not previously been investigated with regard to 
differing tissues within the muscle (see study III). 
 
1.2.2 Selected pain induction techniques in fascia, muscle and tendon 
This section shall review the selected pain induction techniques used in the project. 
 
1.2.3 Hypertonic saline 
Hypertonic saline produces a transient local pain which is described as being similar to 
clinical muscle pain (Graven-Nielsen et al. 1997a;Capra and Ro 2000). Hypertonic saline 
injection is known to induce referred pain and has been used to do so in many structures 
including the following: muscle (Graven-Nielsen et al. 1997a;Graven-Nielsen et al. 
1997b;Graven-Nielsen et al. 1997c), tendon (Kellgren J.H. 1938;Steinbrocker et al. 
1953;Slater et al. 2003), ligaments (Lewis and Kellgren 1939;Inman and Saunders 
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1944;Feinstein et al. 1954), joint and joint related structures (Gerber et al. 1998;Hassett 
and Barnsley 2001;Bennell et al. 2004) (see also Table 1, Appendix 1). The pain intensity, 
quality and distribution of hypertonic saline has been shown to be reproducible for 
individuals over time and repeated injections (Graven-Nielsen et al. 1997a;Graven-
Nielsen et al. 1997b). Thus it is a reproducible means of inducing experimental pain. The 
safety of hypertonic saline use is well established with a recent review finding over 6000 
hypertonic saline injections performed in studies without side-effects (Graven-Nielsen 
2006). Fig. 2 demonstrates a typical visual analogue scale (VAS) pain profile following 
hypertonic saline injection to tibialis anterior tendon. 
 
Fig. 2: Average VAS profile following injection of 0.5ml, 5.8% hypertonic saline to the tendon of tibialis 
anterior muscle. (n=18). Data taken from study I. 
 
 
 
 
 
 
 
 
 
 
Hypertonic saline induces activity in nociceptive group III and IV sensory endings 
(Kumazawa and Mizumura 1977;Hoheisel et al. 2004;Hoheisel et al. 2005) without 
effecting thick group I and II afferent fibres. However, it is not nociceptive specific and 
may cause activity in thermal, contraction and low threshold mechano-sensitive group III 
and IV fibres (Kumazawa and Mizumura 1977). The exact mode or site of action of 
hypertonic saline upon the nerve endings is unknown. It is speculated the hypertonic 
nature of the saline may act through the osmotic gradient to shrink the nerve endings and 
cause activity in the stretch inactivated channel, a variant of the transient receptor 
potential vanilloid 1 (TRPV1) receptor (Schumacher et al. 2000). Alternatively, the ion-
channel TRPV4 (expressed peripherally and centrally) as a mediator of osmolarity may 
be implicated in hypertonic saline induced afferent activity (Alessandri-Haber et al. 2005). 
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1.2.4 Glutamate and capsaicin 
Glutamate is a natural amino acid present in the peripheral and central nervous system in 
humans and is a key mediator in nociceptive activity. Unlike hypertonic saline, the 
suggested mode of action of glutamate is well described. Sensory afferent activity 
induced by glutamate occurs at the ionotropic N-methyl-D-aspartate (NMDA), α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid, kainate (AMPA and KA) (Coggeshall 
and Carlton 1998) and metabotropic (groups I, II and III) receptor types (Walker et al. 
2001;Neugebauer 2002). It has been shown to cause pain in deep muscle tissue with a 
similar profile to that of hypertonic saline (Cairns et al. 2001;Svensson et al. 2003;Cairns 
et al. 2003a;Cairns et al. 2003b;Wang et al. 2004;Svensson et al. 2005;Cairns et al. 2006). 
Glutamate injection causes higher pain intensity in women and greater nociceptive 
afferent activity in female rats compared to males (Cairns et al. 2001). Due to this, in 
order to minimise any variability in the sample population, study IV was performed only 
on males. Application of glutamate to deep muscle results in increased activity in group 
III and IV fibres that is not restricted to purely nociceptive afferents (Cairns et al. 2003a).  
Tendon tissue has been shown to express sensory afferent NMDA receptors (Alfredson et 
al. 2001a) and increased tissue glutamate level is associated with tendinopathy (Alfredson 
et al. 2000;Alfredson and Lorentzon 2002) implying glutamate may be important in 
tendon pain. There are no prior studies profiling the characteristics of glutamate induced 
pain in human tendon tissue (see study IV and Fig. 3). 
 
Capsaicin, familiar as the active constituent of chilli peppers is the agonist for the TRPV1 
receptor found on peripheral and central afferent fibres (Caterina et al. 1997;Caterina and 
Julius 2001). Capsaicin has been employed on numerous occasions as a model to elicit 
deep muscle tissue pain (Arima et al. 2000;Witting et al. 2000;Graven-Nielsen et al. 
2002;Wang et al. 2002;Qerama et al. 2004;Chang et al. 2004;Sohn et al. 2004;Qerama et 
al. 2005;Kumar et al. 2006) with induction of transient, moderate to intense pain. 
Nociceptive activity is elicited in group III and IV afferents, again in a non-specific 
fashion (Hoheisel et al. 2004). The TRPV1 receptor is known to respond to capsaicin, 
heat and protons (Caterina and Julius 2001). This is of interest as tissue injury and 
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inflammation is associated with low pH (McMahon and Koltzenburg 2006), meaning this 
may be a functionally important receptor in clinical pain states such as tendinopathy. No 
previous studies have examined capsaicin pain characteristics in tendon tissue (see study 
IV and Fig. 3). 
 
Fig.3: Average VAS profiles following injection of 5µg (in 0.5ml solution) capsaicin and 0.5ml of 1M 
glutamate solution to tendon of tibialis anterior muscle. (n=12). Data taken from study IV. 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
Additionally, utilising glutamate and capsaicin in a sequential fashion to induce pain has 
shown there may be modulatory activity between these two receptor types. Modulation of 
nociceptive activity following capsaicin injection has been achieved using NMDA and 
AMPA/KA antagonists (Sang et al. 1998;Lam et al. 2005). Facilitation of capsaicin 
response has been demonstrated in deep tissue immediately following glutamate injection 
(Teramoto et al. 2003;Wang et al. 2006). NMDA receptors are expressed in human 
tendon; however expression of TRPV1 receptors in this tissue is not yet established. 
Using capsaicin as a means of inferring TRPV1 expression and investigating modulatory 
interactions between these two receptor types in tendon tissue may reveal similar 
modulatory interactions to that seen in muscle.   
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1.2.5 Eccentric exercise induced delayed onset soreness 
Delayed onset soreness becomes apparent approximately 24-48 hours after performing 
loaded eccentric exercise (Bajaj et al. 2000;Whitehead et al. 2001;Itoh et al. 
2004;Prasartwuth et al. 2005). With DOS, subjects report tenderness on palpation over 
the affected muscle, soreness with movement but no pain at rest (Crenshaw et al. 
1994;Bajaj et al. 2001;Nie et al. 2005a;Nie et al. 2005b;Nie et al. 2005c). In addition, 
maximum voluntary contraction force is decreased (Bajaj et al. 2000;Prasartwuth et al. 
2005) and increases in stiffness and swelling of the muscle is seen (Crenshaw et al. 
1994;Whitehead et al. 2001;Nosaka et al. 2002;Hirose et al. 2004). Loaded eccentric 
lengthening of muscles occurs when the muscle actively contracts to resist a force which 
is causing lengthening of the muscle. This form of lengthening muscular contraction is 
extremely efficient in terms of work-output to energy consumed (Komi et al. 
1987;Caruso et al. 2001) compared to concentric (shortening) or isometric (static) work. 
 
Eccentric exercise to induce DOS is a common endogenous method of experimental pain 
induction utilised in both upper and lower limb muscles eg. quadriceps (Crenshaw et al. 
1994;Baker et al. 1997), triceps surae (Weerakkody et al. 2001;Weerakkody et al. 2003), 
hamstrings (Brockett et al. 2001), forearm extensors (Slater et al. 2003;Slater et al. 2005), 
interosseous muscle of the hand (Bajaj et al. 2001;Bajaj et al. 2002), biceps brachii 
(Nosaka and Clarkson 1996;Barlas et al. 2000) and trapezius (Nie et al. 2005b;Nie et al. 
2005c). Eccentric lengthening protocols have also been utilised as a means of developing 
an animal correlate of human DOS models (Taguchi et al. 2005a;Taguchi et al. 2005b) in 
order to more fully investigate basic nociceptive mechanisms behind the eccentric-
induced increased mechanical sensitivity. In humans, tibialis anterior muscle has not been 
utilised widely as a DOS model perhaps due to methodological difficulties. Only two 
previous studies have utilised eccentric exercise in tibialis anterior. In one (Warren et al. 
2000), delayed soreness was not measured and in the other only a minority of healthy 
subjects actually went on to develop DOS (Birtles et al. 2003). Thus a new means of 
inducing DOS in tibialis anterior was developed (see Fig. 4 and studies II and III).  
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Fig 4: Illustration of new eccentric exercise protocol to induce DOS in tibialis anterior muscle. (A); 
starting position of eccentric exercise corresponding to neutral joint angle depicted in (C). (B); End point 
of eccentric exercise corresponding to full plantarflexion joint angle depicted in (C). On completion of the 
movement, the unexercised leg was extended until weightbearing and used to return the subject back to the 
starting position. (C) Schematic representation of the length-tension relationship of the tibialis anterior 
muscle and its associated joint angle during the eccentric exercise performed. The dotted red line indicates 
the descending limb of the length-tension curve (corresponding to increasing plantarflexion) where the 
main eccentric exercise effect is thought to occur. (Brockett et al. 2002;Bowers et al. 2004) and represents 
the joint angle range over which the new eccentric protocol worked. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In brief, subjects were instructed to stand with the heel of the experimental leg on the 
edge of a 13 cm high platform with flat hands resting lightly on a supporting surface at 
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shoulder level. The other leg was not in contact with the supporting surface. The foot of 
the experimental leg was strapped to a hinged metal footplate that supported the forefoot 
and allowed plantar and dorsi-flexion around the ankle joint. Subjects then slowly 
lowered the foot from the neutral ankle position to a fully plantar-flexed position; all the 
while tibialis anterior working to eccentrically control the lowering of bodyweight. The 
other leg was then brought into contact with the supporting surface and used to return to 
the starting position. In this way tibialis anterior muscle of the experimental leg was 
made to work solely eccentrically. This was a very efficient new method of inducing 
DOS in tibialis anterior. It may be that prior methods utilising a KinCOM dynamometer 
(Birtles et al. 2003) did not work the muscle toward sufficiently long lengths where the 
eccentric effect is primarily thought to occur (Jones et al. 1997). 
 
It is commonly thought that eccentric exercise is caused by disruption at the level of the 
sarcomere (Morgan and Proske 2004) to the contractile apparatus. Alteration to the 
ultrastructure of the myofibril is reported, with Z-disc streaming (Fielding et al. 
1993;Friden and Lieber 2001) and cytoskeletal protein loss observed (Lieber et al. 2002). 
This has historically been seen in terms of damage to the muscle (Stauber et al. 
1990;Fielding et al. 1993) with increases in putative inflammatory markers such as serum 
creatine kinase (CK) and neutrophil levels taken as evidence of an inflammatory response 
(Nosaka and Clarkson 1996;MacIntyre et al. 1996;MacIntyre et al. 2000). The delayed 
onset soreness was attributed to peripheral sensitisation secondary to the assumed 
inflammation. However, more recent work brings this assumption into question. Serum 
CK profile does not match the soreness profiles; indeed serum CK can rise significantly 
post eccentric exercise in the absence of any evidence of an eccentric induced 
inflammatory response (Malm et al. 2004). Recent comparative studies between 
concentric and eccentric exercise found no evidence of an inflammatory response 
following eccentric exercise compared to control or concentric exercise groups (Malm et 
al. 2000;Malm et al. 2004). In reinforcement of this, anti-inflammatory medication has 
been shown to have little effect on inflammatory markers (Peterson et al. 2003) or 
perceived soreness post eccentric exercise (Semark et al. 1999;Loram et al. 2005). It is 
now proposed that the ultrastructural effects seen following eccentric exercise are more 
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properly viewed as an adaptive immunological response to exercise rather than tissue 
damage (Malm et al. 2000;Friden and Lieber 2001;Yu et al. 2002;Yu and Thornell 
2002;Malm et al. 2004;Yu et al. 2004). Further it has been proposed that the tissue 
responsible for DOS may in fact be connective (fascia/epimysium) rather than muscle 
(Malm et al. 2004). 
 
Regardless of whether eccentric exercise effects tissue damage or a muscle adaptation 
response, it is apparent that with time, sensitisation of thin fibre afferents by algesic 
substances is likely (Tegeder et al. 2002). The tenderness and soreness 24-48 hours post 
eccentric exercise would imply some degree of peripheral sensitisation of sensory thin 
afferents. Recent data from animal models confirms facilitation of peripheral thin afferent 
fibres 48 hours post eccentric exercise (Taguchi et al. 2005a;Taguchi et al. 2005b) (see 
study III). In addition, evidence for altered central pain processing mechanisms in DOS is 
gathering. Facilitation of temporal summation (Bajaj et al. 2000;Nie et al. 2005b), 
evidence of thick fibre involvement (Barlas et al. 2000;Weerakkody et al. 
2001;Weerakkody et al. 2003) and facilitated referred pain (Study II) during DOS is 
established suggesting central sensitisation processes are at work. 
 
2. Mechanical sensitivity during experimental pain 
2.1 Delayed onset soreness 
Increased mechanical sensitivity (hyperalgesia) is a hallmark of eccentric exercise 
induced delayed onset soreness. It has become apparent that the hyperalgesia seen in 
DOS is not evenly distributed over the affected muscle. Whilst the most commonly 
reported site of tenderness in DOS is the mid muscle belly region (Bajaj et al. 
2000;Weerakkody et al. 2001;Whitehead et al. 2001;Slater et al. 2003;Slater et al. 2005), 
other studies including animal studies report the musculotendinous junction being 
involved (Baker et al. 1997;Taguchi et al. 2005b;Nie et al. 2005c) which was confirmed 
in the current animal component of study III (see Fig. 5).  
 
Fig. 5: Examples of receptive fields (outlined and indicated by probe) assessed in control (CTR) and 
eccentrically exercised (ECC) rat extensor digitorum longus muscles. Note that the identified mechanically 
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sensitised receptive fields in the ECC group are clustered mainly around the musculotendinous junction 
area. Data taken from animal component of study III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In study II, 38 subjects with DOS had pressure pain thresholds measured at muscle belly, 
tendon-bone junction and distal tendon sites. Both muscle belly and tendon-bone junction 
sites were hyperalgesic but distal tendon was unaffected (see Fig. 6). This confirms 
previous findings but may not fully reflect DOS mechanical sensitivity patterns. Because 
only three sites were assessed and the sample size was such that sensitivity to change was 
high; it is possible that more extensive spread of hyperalgesia was missed or that the sites 
assessed were not the most sensitive areas.  
 
Fig. 6: Representation of mechanical sensitivity (represented by average PPT, n=38) pre and during DOS; 
assessed at distal tendon, muscle belly and tendon-bone junction sites. (*) significantly decreased 
compared to pre DOS sensitivity. Data taken from study II. 
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A progression of specificity in the search for mechanical sensitivity post eccentric 
exercise is seen in the receptive field assessment of presumed group IV afferent fibres 
post eccentric lengthening protocol in the animal component of study III. As shown in 
Figure 5, receptive fields found to be mechanically sensitised were located mainly 
around the musculotendinous junction area. However this may not reflect the full DOS 
spatial effect as the full muscle length was not assessed for mechanical sensitivity. 
 
Widespread patchy distributions of sensitive loci during DOS has been demonstrated 
(Weerakkody et al. 2001;Weerakkody et al. 2003) and this is confirmed in the human 
component of study III.  In this experiment it was important to specify the site of 
maximal mechanical sensitivity over the muscle during DOS. Eight sites distributed 
along the muscle from proximal tendon-bone junction area to distal musculotendinous 
junction were assessed. Post eccentric exercise, the change from baseline in mechanically 
sensitivity was assessed for each site and the site with the greatest relative change was 
deemed the area of maximal sensitivity and by extension the site of greatest DOS 
sensitisation. While muscle belly was a common site of maximal sensitivity there was 
considerable variation in the spatial distribution of these areas between subjects (see Fig. 
7). 
 
Fig.7: Visual demonstration of mechanical sensitivity (as represented by average PPTs, n=13) changes at 
eight sites along tibialis anterior muscle during DOS. Open circles represent increased sensitivity, filled 
represents decreased sensitivity (compared to pre eccentric exercise baseline). ‘X’ in open circles 
represents site of maximal sensitivity for each subject. Note the spatial distribution in site of maximal DOS 
induced mechanosensitivity. Data taken from study III. 
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This study established the site of maximal sensitivity during DOS; however, as the fascia 
directly overlies the muscle, it is not possible to make mechanosensitivity discriminations 
between fascia and deep muscle. Other more selective techniques are required (see 
Chapter 3). 
 
There is no obvious explanation for this variation in mechanosensitivity during DOS. 
Numerous factors may be involved. Evidence points to type II fibres being preferentially 
utilised in a novel eccentric lengthening task (Warren et al. 2000) and it is reported that 
eccentric exercise preferentially induces damage/adaptation in type II muscle fibres in 
animals (Lieber and Friden 1988) and in humans (Warren et al. 2000). Additionally, it is 
known that muscle fibre type proportions vary between muscles and regions within 
muscles in humans (Henriksson-Larsen et al. 1983;Dahmane et al. 2005). It may be that 
the spatial variability in sensitivity post eccentric exercise found in study III was 
influenced by factors such as fibre type variability in the muscle and between subjects. It 
is possible this is a reflection of the specific properties of the muscle and the subject 
assessed.  
 
2.1.1 Hypertonic saline 
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Local mechanical sensitivity changes during hypertonic saline induced pain have 
previously been investigated in muscle tissue, ligaments, tendon/fascia and joint and 
associated structures (see Appendix 1, Table 1). For muscle, the results are ambiguous as 
hyperalgesia is reported in response to both hypertonic and isotonic saline (Jensen and 
Norup 1992;Graven-Nielsen et al. 1998) or is found not to influence muscle mechanical 
sensitivity (Babenko et al. 1999b). There is no quantitative data for the studies performed 
on the other tissues mentioned in appendix 1 making their results difficult to interpret. 
There may be a number of mechanisms influencing peripheral sensitivity during saline 
induced pain. Injury induced by needle insertion may cause release of glutamate (Tegeder 
et al. 2002) or other endogenous substances which could lead to nociceptor sensitisation. 
While this is possible it does not explain the lack of change in mechanical sensitivity 
commonly seen post hypertonic saline injection (Babenko et al. 1999b;Slater et al. 
2003;Slater et al. 2005). Afferent stimulation may lead to release of endogenous 
substances (glutamate, SP, CGRP) via a local axon reflex mechanism (Pedersen-
Bjergaard et al. 1991;Tegeder et al. 2002;Loaiza et al. 2002) which may be a means of 
peripheral sensitisation. Lastly, it may be that afferent activity caused by the pressure 
algometer (used to assess mechanosensitivity) can summate with the afferent activity 
induced by the hypertonic saline in a centrally mediated process thereby leading to the 
perception of mechanical hyperalgesia (Graven-Nielsen et al. 1998). 
 
Study I demonstrated significant reductions in pressure pain threshold (PPT) during pain 
in (and measured at) the tendon and tendon-bone junction sites. No change in PPT at the 
muscle belly was seen following pain induced at this site. This reduction in 
tendon/tendon-bone PPT was transient as values returned to baseline as soon as pain 
resolved. Hypertonic saline injected to the tendinous structures caused greater pain than 
muscle belly injection and it is likely the increased saline pain at these sites, in 
combination with the stimulation provided by the algometer, resulted in an afferent input 
summation effect causing pain to be perceived at lower pressures compared to baseline. 
From study I it may be inferred that hypertonic saline did not reliably induce peripheral 
sensitisation in tendon tissue. In this study, occasionally significant hypoalgesia was seen 
in distant sites following either hypertonic or isotonic saline injection at tendon or 
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tendon-bone junction. Physiological adaptation to repeated mechanical testing is reported 
and likely explains hypoalgesia following isotonic saline injection (Svensson et al. 2003). 
In contrast, it is thought that hypoalgesia at remote sites following painful stimulation is 
probably mediated through a descending noxious inhibitory control mechanism (Le Bars  
et al. 1979). This serves to highlight some of the difficulties and potential problems 
involved in repeated psychophysical testing of human subjects. 
 
Study II examined mechanical sensitivity during DOS at muscle, tendon and tendon-bone 
sites. Subjects with DOS had a tendon, tendon-bone junction or muscle belly hypertonic 
saline injection. In this case no reduction in PPT at any site was seen during saline-
induced pain. Due to presumed afferent sensitisation during DOS it would be expected 
that hypertonic saline injection may lead to increased mechanosensitivity via summation 
of afferent input or, following injection, through an antidromic sensitisation of already 
sensitised nociceptors. It has been suggested there may be a discrepancy between central 
afferent processing of saline pain and pressure stimulation during DOS (Weerakkody et 
al. 2003) with the main theory being that during DOS, it is actually thick-fibre afferents 
that mediate the soreness (Weerakkody et al. 2003). If this were the case it could explain 
why mechanosensitivity during DOS is seemingly unchanged by hypertonic saline 
injection: although non-specific in action, hypertonic saline does not excite thick fibre 
sensory afferents (Kumazawa and Mizumura 1977). However, basic animal studies 
(including study III) (Taguchi et al. 2005a;Taguchi et al. 2005b) provide good evidence 
that thin fibre sensory afferents are mechanically sensitised post eccentric lengthening 
exercise and as such it seems logical that hypertonic saline application could induce 
mechanical hyperalgesia during DOS. It has been  postulated that post eccentric exercise 
the mechanical hyperalgesia may cause a sufficient nociceptive barrage such that further 
thin-fibre response to additional stimuli may not be possible; in effect there may be a 
sensory afferent ‘saturation’ (Marqueste et al. 2004). Lastly, due to the suggested ‘all-or-
nothing’ response caused by hypertonic saline (Hoheisel et al. 2005) there remains the 
possibility that hypertonic saline cannot further sensitise afferents that are already 
sensitised. 
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2.1.2 Glutamate and capsaicin 
Similar to hypertonic saline, the effects of deep muscle injection of glutamate are 
somewhat ambiguous, with increased (Svensson et al. 2003;Cairns et al. 2006) and 
unchanged (Cairns et al. 2003a;Ge et al. 2005) mechanosensitivity observed. Further, 
while glutamate levels are increased in both muscle and tendon clinical pain patients the 
relationship is ambiguous with increased glutamate levels related to increased mechanical 
sensitivity in trapezius myalgia patients but apparently unrelated to mechanical sensitivity 
in tendinopathy patients (Alfredson and Lorentzon 2003;Rosendal et al. 2004). In study 
IV glutamate had a similar pain profile to hypertonic saline (and no mechanical 
hyperalgesia was seen during saline pain). As suggested previously, if under some 
circumstances increased sensitivity can be mediated via a central summation of induced 
pain and pressure stimulation then the modest pain levels following glutamate injection 
may not have provided sufficient afferent input to allow this proposed summation to 
occur. Secondly, it remains unknown exactly which receptor types mediate mechano-
transduction. There is speculation that the TRPV receptor family might be important in 
this regard (Lin and Corey 2005). Mice with TRPV4 receptor knock-out show decreased 
response to noxious mechano-stimulation (Suzuki et al. 2003) and mice lacking TRPV1 
exhibit decreased response to the mechanical stimulus supplied by bladder filling (Birder 
et al. 2002). Given the established modulatory interactions between NMDA antagonists 
and TRPV1 receptor activity (capsaicin induced), it is apparent that the link between 
glutamate and mechanosensitivity is complex and as yet not fully understood. 
 
Capsaicin intramuscular injection on the other hand reliably reduces PPT during induced 
pain (Arima et al. 2000;Witting et al. 2000;Qerama et al. 2004;Kumar et al. 2006). This 
increase in mechanosensitivity can have a prolonged duration of up to several hours 
(Arima et al. 2000;Witting et al. 2000). 
 
In study IV injection of glutamate to the tendon did not change mechanosensitivity 
measured at the tendon. Hypertonic saline injected immediately after glutamate did not 
change mechanosensitivity during pain (in contrast to study I but the preceding injection 
of glutamate in this study makes direct comparison difficult). Capsaicin injection after 
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glutamate did not cause additional reduction in PPT during pain as compared to capsaicin 
injection alone. This was despite a facilitation of the pain (see chapter 3) perceived 
during capsaicin injection preceded by a glutamate injection compared to capsaicin 
injection alone. Therefore, it may be inferred that tendon tissue in a resting control 
condition does not display hyperalgesia subsequent to glutamate induced pain. Secondly, 
glutamate may cause sensitised conditions in the tendon tissue such that perceived pain to 
subsequent capsaicin injection is facilitated but this is not reflected by further increases in 
mechanosensitivity. Again, this highlights the complex relationship between glutamate 
and mechanosensitivity during control, and possibly also clinical conditions. 
 
Capsaicin injection in study IV caused significant increases in mechanosensitivity at the 
tendon injection site and 2 cm proximal. Unlike previous studies however (Arima et al. 
2000;Witting et al. 2000), the PPT reductions were transient and mechanosensitivity 
returned to baseline levels following resolution of pain. In addition, following capsaicin, 
both glutamate and hypertonic saline pain caused transiently increased 
mechanosensitivity which was manifest only during pain. Due to high perceived pain 
levels, the amount of capsaicin injected was 5μg which is ten times lower than that 
commonly injected in muscle pain studies (Graven-Nielsen et al. 2002). While it is not 
possible to exclude capsaicin induced peripheral sensitisation (there could have been 
short lived peripheral effects which, due to the small amount of capsaicin were resolved 
by the time pain resolved and post pain PPT recordings were taken) it seems most likely 
that hyperalgesia was appreciated again via a central summation effect. It has been 
demonstrated that phosphorylation of spinothalamic tract cell NMDA receptors occurs 
within 30 minutes post capsaicin injection (Zou et al. 2000) in rats. Phosphorylation of 
NMDA receptors is thought to be an important part of the central sensitisation process 
(Woolf and Salter 2000).  It is possible that early stage central sensitisation could result in 
increased response to the subsequent combined stimuli of induced pain (glutamate and 
hypertonic saline) and pressure stimulation (hyperalgesia) as opposed to pressure 
stimulation alone (unchanged post-capsaicin-induced pain mechanical sensitivity).  
 
3. Pain Intensity 
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One of the many factors influencing perceived pain may be innervation density of the 
painful tissue (Saxler et al. 2006). Increased pain from hypertonic saline injection at 
motor end-plates compared to control (non-end-plate) sites in the muscle are suggested to 
be reflective of increased innervation density at these sites (Qerama et al. 2004). The 
current studies (I to III) reveal significant differences in perceived pain intensity when 
comparing between tendon, tendon-bone junction, fascia and muscle which is suggestive 
of differences in sensory innervation density between these tissues. 
 
3.1 Hypertonic saline 
Studies I and II reveal an overall trend toward greater pain following hypertonic saline 
injection at tendon-bone and tendon compared to muscle belly. It was shown in study I 
that isotonic saline produced negligible pain in tendinous structures. Given the obvious 
differences in tissue composition and vascularity between muscle and tendon it was 
important to establish that simple mechanical deformation of the tissues by a saline bolus 
did not provoke pain. The greater pain perceived following hypertonic saline tendon 
injection compared to muscle is a stable consistent finding (see Fig. 8).  
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Fig.8: Demonstration of consistency of greater pain induced by hypertonic saline (5.8% 0.5ml) following 
tendon injection compared to muscle belly injection. All three average VAS graphs above show 
significantly greater area under the VAS-time curve while study 2 also displays increased pain intensity 
compared to muscle belly injection. Note:  the lower graph is data taken from an unpublished manuscript. 
 
Studies I and II established that the tendon-bone junction area was significantly more 
sensitive to hypertonic saline than the muscle belly. The possibility remains that 
following injection to this site; periosteal tissue which is known to be highly sensitive 
(Graven-Nielsen et al. 1997a) may have been affected by the saline. However, great care 
was taken in each study to avoid needle contact with (or if contact was made, retract the 
needle appreciably) the bone. If nociceptive innervation density is reflective of perceived 
pain, it is logical to suggest this area is more densely innervated than muscle belly. 
Nociceptors are not merely signallers of pain; they also serve a protective warning 
function (Mense 1993). The origin or tendon-bone junction of tibialis anterior is fleshy in 
nature (Moore 1992). Injection to this area will undoubtedly encompass 
musculotendinous junctions as well as tendon-bone transitional areas. The 
musculotendinous junction is the area most likely to be damaged in strain injuries 
(Nikolaou et al. 1987;Kirkendall and Garrett 2002;Cross et al. 2004). From a self-
protection point of view, it is logical if this vulnerable area is more densely populated 
with nociceptors which could alert the system to potentially damaging situations.  
 
Following studies I and II it can be inferred that tendon tissue is more sensitive than 
muscle belly to hypertonic saline injection. This fits well with observed higher 
innervation densities in rat peritendineum tissue compared with the associated muscle 
(Mense and Simons 2001). It may be implied that this current result reflects higher 
innervation density in tendon/paratendinous tissue than muscle. However, it should be 
noted that this series of studies aimed to inject at the surface of, and around the tendon. 
At no point were the injections deliberately targeted intra-tendinously to the body of the 
tendon. Therefore, it is most likely that this present finding reflects innervation in the 
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paratendon tissue and the most superficial layers of the tendon body. Clinically, 
paratendinous tissue is important as sclerosing the neovessels associated with 
tendinopathy in this outer layer of the tendon produces marked reductions in pain leading 
to the assumption that the pain of tendinopathy chiefly originates from nociceptive 
afferents in this tissue (Alfredson and Ohberg 2005a;Danielson et al. 2006). It must be 
acknowledged that the behaviour of the saline bolus may have had an effect on pain 
perceived. A hypertonic saline bolus injected to the muscle tends to distribute in a 
vertical plane (Graven-Nielsen et al. 1997d). The fluid mechanics of saline injected to the 
tendon is not known. If the saline were to sit in a pool, it may provide ongoing 
stimulation such that a temporal summation of pain may account for greater perceived 
pain. A similar process is suggested to account for high levels of pain post saline 
injection to the subcutis (Lindahl 1969). 
 
A selective method of delivering targeted hypertonic saline injections to superficial 
fascia/muscle was developed in order to investigate comparisons between fascia and deep 
muscle sensitivity (study III). This study established the increased sensitivity to saline 
injection of muscle fascia/epimysium compared to deep muscle tissue. This finding 
confirms clinical anecdotal experience in which stimulation of fascia is consistently 
described as more painful than deep muscle tissue. Fascia/epimysium is continuous with 
the connective tissue of the muscle. Muscle connective tissue (endomysium, perimysium, 
epimysium, fascia) is a continuous structure that invests throughout the entire muscle and 
continues beyond the muscle to form tendons (O'Brien 1997). This pervasive tissue is a 
force transmitter unlike muscle fibres which are force generators. It is sensible that 
tissues involved in the transmission of force have high innervation densities of afferent 
fibres. This may be reflective of the ‘early warning’ function of nociceptors. Secondly, 
fascial/epimysium tissue may be particularly vulnerable during eccentric lengthening (see 
section 3.2) which occurs commonly in everyday activities. Again, highly developed 
afferent feedback may be important in minimising injury. 
 
3.2 Hypertonic saline pain during DOS 
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Study II demonstrated tendon and tendon-bone tissue cause significantly greater pain 
following saline injection than muscle belly under control conditions. Interestingly, 
despite tendon-bone and muscle being mechanically sensitised during DOS; repeat 
injections of saline in the presence of DOS showed no significant difference compared to 
baseline (pre eccentric exercise) conditions in response to saline (see Fig. 9). 
 
Fig. 9: Average VAS profiles following muscle belly and tendon-bone junction hypertonic saline injection 
pre and during DOS. The lack of a facilitated pain response at these sensitised sites is noteworthy. (n=13). 
Data taken from study III. 
 
 
 
 
 
 
 
 
 
 
 
As suggested previously, this may be reflective of a DOS induced afferent saturation 
(Marqueste et al. 2004). Due to this ‘saturation’ the thin fibre afferents putatively 
sensitised by DOS may be unable to respond to hypertonic saline with additional 
excitation. Therefore using this line of reasoning, hypertonic saline stimulation of the 
DOS affected afferents is unlikely to be reflective or comparable with results obtained 
during control conditions. However, by increasing the specificity of assessment site (see 
Fig. 8) and the tissue injected, study III demonstrated facilitated response to hypertonic 
saline in DOS affected tissues (see Fig. 10). 
 
Fig. 10: Average VAS profiles (n=13) following hypertonic saline injection targeted toward muscle belly 
and fascial tissues. Profiles represent pain perceived in response to saline injection pre and during DOS. 
(*) Significantly increased pain intensity at fascia level during DOS. Data taken from study III. 
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 In this study, DOS was induced, the site of maximum mechanical sensitivity established 
and then selective injection of hypertonic saline targeting fascia/epimysium and muscle 
belly was undertaken. The animal component of this study examined the response of 
hypertonic saline superfused to the epimysium and muscle tissue of extensor digitorum 
longus (EDL) muscle in rats 48 hours post eccentric lengthening. One of the reasons 
previous studies may not have found changes in response to hypertonic saline injected to 
the muscle tissue pre and during DOS may have been due to not establishing and 
subsequently injecting the site most mechanically sensitised by the DOS. However, the 
human component of study III disputes this reasoning by establishing that despite 
injecting into the area of deep muscle tissue displaying the most mechanical sensitisation, 
there was no significant response difference between pre and during DOS (see Fig. 11). 
These injections were performed at the most sensitive point of the muscle during DOS 
and were therefore considered to be sites of maximal DOS manifestation. Notably though, 
injection of hypertonic saline directed toward fascia/epimysium at this maximal 
mechanically sensitised site of the DOS affected muscle was found to be significantly 
more painful than the same injection to the same tissue at the corresponding site of the 
contralateral unexercised leg. The implication of this is that fascial/epimysium connective 
tissue is preferentially sensitised by DOS subsequent to eccentric exercise.  
 
However, this suspected sensitisation of peripheral fascial nociceptors may not fully 
explain the whole situation during DOS. The animal component of study III found no 
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significant difference between eccentrically exercised and control muscles when 
hypertonic saline was superfused to the identified receptive fields in a muscle-nerve 
preparation (see Fig. 11). 
 
Fig. 11: Average afferent impulses per second recorded from an unexercised rat EDL muscle and an 
eccentrically lengthened, mechanically sensitised rat EDL muscle following exposure to hypertonic saline. 
Control (CTR) group n=14; eccentric (ECC) group n=17. Data taken from animal component of study III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
This may be explained by a number of factors. Firstly, rat EDL does not have a thickened 
epimysium forming a distinct fascia like the human tibialis anterior. Secondly, eccentric 
protocols in animals by definition are not voluntary, unlike human eccentric exercise. 
This means it is not possible to completely rule out some degree of muscle fibre tearing 
during the eccentric protocol potentially changing the nature of the induced sensitivity 
compared to the human component of the study. Thirdly, it is possible that some degree 
of afferent saturation (Marqueste et al. 2004) as previously discussed, may be involved 
thereby masking responses to hypertonic saline. All of these factors could potentially 
influence the response to superfusion of hypertonic saline to the muscle/epimysium. But 
of more interest, it may be that the exclusively peripheral nature of the muscle-nerve 
preparation does not allow for assessment of involvement of central processes during 
DOS. Even if hypertonic saline does induce an ‘all or nothing’ response in nociceptive 
 n/s 
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afferents and thus not be ideal for assessing peripheral sensitisation (Hoheisel et al. 2005), 
the acknowledged involvement of central pain processes during DOS (Bajaj et al. 2000) 
could result in increased pain being perceived to the potentially unchanged level of 
afferent input (compared to control injections) from the peripheral nociceptors following 
hypertonic saline injection. In effect, if fascial/epimysium tissue is sensitised by the 
eccentric exercise, the ongoing nociceptive activity from this tissue could sensitise the 
central (dorsal horn) neurones they communicate with. The result is that increased pain 
will be perceived to afferent stimuli. Thus, whether the perceived pain is reflective of 
central or peripheral ‘increased pain gain’ induced by fascial/epimysium sensitisation, it 
can be argued that the original source of the sensitising activity lies with 
fascial/connective tissue. 
 
A selective DOS event in fascial/connective tissue may be explained by the manner in 
which eccentric damage/adaptation is thought to occur. Eccentric damage/adaptation 
occurs during the longer phase (longer muscle length) of the muscles length/tension 
relationship (Jones et al. 1997;Morgan and Proske 2004;Bowers et al. 2004). If, during 
the eccentric exercise, the muscle becomes inefficient at longer lengths due to sarcomere 
disruption, then connective tissue may be placed under increasing strain.  It has been 
shown that absorbed energy of the musculotendinous unit during strain is significantly 
higher when the muscle is active as opposed to silent (Nikolaou et al. 1987), which, put 
simply, means that active, patent muscles are better able to deal with strain compared to 
muscles becoming inefficient and partially inactive (due to sarcomere disruption).  Thus, 
during eccentric exercise, connective tissue may become vulnerable to excess strain 
forces if the muscle activity is impaired as myofibrillar disruption occurs. If this happens, 
it may induce the eccentric DOS effect in the fascia/epimysium connective tissue exposed 
to the increased strain/stress with the result that fascial/epimysium connective tissue 
nociceptive afferents become sensitised. This explanation fits nicely with the decrease in 
DOS perception seen following repeated bouts of eccentric exercise. Chronic adaptation 
to eccentric exercise has been shown in the form of sarcomerogenesis (Butterfield et al. 
2005) and persistent shifts in the muscle length/tension relationship towards longer 
lengths (Prasartwuth et al. 2006). In turn, for the muscle, this would result in a greater 
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ability to perform work at longer lengths, resulting in stress shielding of fascia/connective 
tissue and subsequently less DOS induced/perceived. 
 
3.3 Glutamate and Capsaicin induced pain 
Functional metabotropic/ionotropic glutamate receptors in tendon tissue were implied by 
the results of study IV. Also, capsaicin caused moderate to high levels of pain in tendon 
tissue. This was despite the dose being 10 times (5μg) less than that used in previous 
muscle pain models (50μg) (Graven-Nielsen et al. 2002) to produce similar peak pain 
levels. This large difference in dose may be reflective of a higher TRPV1 afferent density 
population in tendon compared to muscle. Alternatively it may be as a result of the 
injected bolus forming a depot around the tissue, resulting in temporal summation. Either 
way, it points to TRPV1 receptors being functional in human tendon tissue and therefore 
the role of these receptors in clinical tendon pain should be further investigated. 
 
The facilitated pain response of capsaicin injected immediately after glutamate compared 
to capsaicin injected alone confirms the findings of Wang et al. (2006) who demonstrated 
significant increases in pain from a capsaicin injection post glutamate injection compared 
to a capsaicin injection post isotonic saline injection. This may be due to sensitisation of 
peripheral receptors by glutamate. By using nociceptive reflex induced jaw muscle 
activity as a measure, it was found that pre-injection of a NMDA antagonist reduced 
nociceptive response to capsaicin injection in rat temperomandibular joint when 
compared to placebo pre-injection (Lam et al. 2005). Further, intravenous infusion of an 
AMPA/KA antagonist was found to reduce pain and hyperalgesia (compared to placebo 
infusion) caused by injection of intra-dermal capsaicin (Sang et al. 1998). Thus, there is 
interaction between TRPV1, NMDA and AMPA/KA receptors. Confirming this in 
human tendon tissue raises the possibility of developing appropriate receptor antagonist 
therapies which could reduce pain mediated not only via peripheral glutamate but also 
TRPV1 receptors. 
 
4. Referred pain 
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Referred pain is a common clinical occurrence. Similarly in experimental pain studies it 
is frequently observed (Laursen et al. 1997;Graven-Nielsen et al. 1997a). A number of 
theories have been proposed attempting to explain this phenomenon. Evidence is 
mounting for a process by which central dorsal horn neurones, with time, become 
sensitised by peripheral noxious input and activate latent synaptic connections with 
surrounding neurones in the dorsal horn (Hoheisel et al. 1993) forming, in animals, new 
neuronal receptive fields and in humans the perception of referred pain (Graven-Nielsen 
2006). Injection of bradykinin (causing activity in nociceptive afferent fibres) to rat 
muscle caused new receptive fields of dorsal horn neurons to appear, distinct from and 
outwith the boundaries of the original receptive fields mapped prior to nociception 
induced by bradykinin (Hoheisel et al. 1993). This has been suggested to be evidence of 
unmasking of latent synaptic connections in the dorsal horn between previously inactive 
(now active) synapses and neighbouring neurones. Further support for this ‘facilitation’ 
or ‘unmasking’ theory suggested to form the basis of referred pain is again provided by 
animal studies. Induction of an experimental myositis in rat gastrocnemius-soleus (GS) 
muscle had the effect of significantly increasing the population and spinal segmental 
distribution of dorsal horn-neurones excited by GS A-fibre stimulation (Hoheisel et al. 
1994). The most logical explanation of this is activation of a previously silent network of 
widely distributed synaptic connections. In humans this may lead to referred pain 
perception as a result of the excitation of the neurones or misinterpretation of normal 
afferent activity in this sensitised, newly opened, expanded dorsal horn network (Graven-
Nielsen 2006). It is apparent that time is likely to be an important factor in this process. A 
certain length of time of nociceptive activity/pain seems to be required to facilitate pain 
perception in humans (Graven-Nielsen et al. 1997c) and for the development of new 
receptive fields in animals (Hoheisel et al. 1993;Hoheisel et al. 1994). Study I confirmed 
the suspected importance of time in this proposed referred pain process. Tonic 
stimulation as compared to one-off stimulation (stimulation to referred pain appearance 
or subject tolerance) caused enlarged pain areas and more frequent perception of referred 
pain. This highlights the time taken for the peripheral input to make or open latent 
synaptic connections (see Fig. 12) if this is indeed the mechanism in operation behind 
referred pain. 
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Fig12: Referred pain diagrams illustrating the temporal requirement of referred pain mechanism. Top 
row: Referred pain diagrams following a one-off brief mechanical stimulation. Bottom row:  Referred and 
local pain diagrams following sustained mechanical stimulation. Data taken from study I. 
 
Studies I, II and IV demonstrated that tendinous structures do exhibit referred pain with 
varying frequency (but roughly in line with muscle belly frequency). Referred pain is 
generally associated with higher pain intensities (Laursen et al. 1997;Graven-Nielsen et al. 
1997b;Graven-Nielsen et al. 2000) which  was observed at these sites in studies I and II. 
In study III, fascial tissue was shown to exhibit referred pain, however despite 
significantly higher pain intensities not to the same extent as muscle tissue. This may 
simply reflect fascial tissue nociceptive characteristics and is in line with previous 
findings (Kellgren J.H. 1938). 
 
The finding of increased referred pain and enlarged pain areas during DOS to stimuli that 
was no more painful than pre DOS (study II) may be seen as providing further (indirect) 
support to the notion of referred pain being dependent on a central sensitisation process 
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opening latent synaptic networks/connections in the dorsal horn. As already stated there 
is an acknowledged role of central sensitisation during DOS (Bajaj et al. 2000;Barlas et al. 
2000;Weerakkody et al. 2001;Weerakkody et al. 2003). Therefore, the increased referred 
pain response to hypertonic saline injection (with induced pain of no greater intensity 
than pre DOS) could have been a result of the previous ongoing (approximately 12 hours) 
nociceptive activity due to the DOS which may have caused central sensitisation and 
facilitated opening of latent neuronal connections to a far greater extent than the brief 
afferent barrage supplied by hypertonic saline injected in a non-DOS affected muscle. In 
study II, tendon-bone and muscle belly sites were shown to be affected by DOS 
(hyperalgesia). During DOS at these sites, hypertonic saline injection (despite being of 
similar intensity as control conditions) induced significantly higher frequency of referred 
pain (muscle belly) and significantly greater areas of enlarged pain (tendon-bone) 
compared to unexercised conditions (see Figure 13). 
 
Fig 13: Top row shows pain areas following hypertonic saline injection to muscle (n=13) and tendon-bone 
(n=11) tissue in a control state. Bottom row shows the same injection to the same tissue during DOS. Note 
the areas of local pain (mid and proximal muscle areas) and the increased frequency of mapping of pain in 
the ‘muscle belly’ group at the anterior ankle area (typical referred pain area of tibialis anterior) 
compared to the pre DOS areas. During DOS, injection of tendon-bone tissue caused much greater area of 
pain including to areas not normally seen (posterior leg) with injection of this area. Data taken from study 
II. 
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This has not been shown before. Presently, increased referred or enlarged pain areas have 
been correlated with higher pain intensities (Graven-Nielsen et al. 2000). Potentially this 
mechanism could also apply to chronic, centrally sensitised patients (fibromyalgia, 
whiplash etc.) in which an acute stimulus of comparatively low intensity might lead to 
more widespread pain compared to a healthy control. Early results suggest this is in fact 
the case with chronic whiplash sufferers displaying greater areas of referred pain than 
healthy controls despite the induced pain being perceived at the same intensity (Kosek et 
al. 2006).  
 
5. Summary  
This PhD study investigated the sensory manifestations of tendinous, fascial and muscle 
tissues in relation to experimental pain. It has been established that sensitivity to 
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hypertonic saline in fascial and tendinous structures is higher than in muscle tissue 
(studies I, II and III). This is clinically relevant as it implies that the contribution of 
tendinous and fascial structures to the clinically prevalent entity ‘muscle pain’ needs to 
be carefully considered. Increased mechanical sensitivity at tendinous sites during 
experimental pain (saline, glutamate and capsaicin) is probably not the result of 
peripheral sensitisation (studies I and IV), instead a central summation between induced 
pain and mechanical stimuli may occur, leading to the perception of lowered mechanical 
pain thresholds. This may be important as chronic tendinopathic pain patients are likely 
to display central sensitisation of pain processing mechanisms and as such the commonly 
felt mechanical sensitivity in these conditions may be heavily influenced by central 
mechanisms. When the lack of an inflammatory process in these patients is considered 
(with possible subsequent lack of peripheral sensitising substances), this central 
mechanism of mechanosensitivity may be important and worthwhile targeting in future 
pain management strategies. Purely tendon structures are probably not sensitised by acute 
induction of DOS (study III). However, it was demonstrated that fascial/epimysium 
connective tissue does display increased sensitivity during the sensitised conditions of 
DOS and may be the main site of eccentric exercise induced DOS effect. This could give 
an insight into the damaging effects of repeated eccentric exercise which suggests that 
connective tissue may be exposed to excessive stress under these contraction conditions 
(thus becoming sensitised) when the myofibrillar contractile mechanism becomes 
inefficient. Further, in DOS sensitised conditions referred pain may be more frequently 
appreciated (compared to pre DOS) in response to stimuli of similar pain intensity as that 
induced pre DOS (study II). Lastly, functional glutamate and TRPV1 receptors are shown 
to be functional in tendon tissue (study IV) and there appears to be some modulation of 
response between these receptor types. This points to a need to investigate these receptors 
in clinical tendon pain. It is currently unknown (but certainly worth investigating) if 
modulation of activity in both these receptor types can be achieved by development of 
antagonists targeting NMDA receptors in clinical situations. This PhD project has 
illuminated some of the mechanisms and characteristics of pain in human tendon, fascial 
and muscle tissue. The results may have particular implications for treatment and 
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possibly prevention of tendon pain. The model below outlines these findings and how 
they may ‘fit’ into the clinical understanding of this common problem. 
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Fig 14: Eccentric exercise may be involved in the development of tendon/connective tissue injury 
secondary to a possible preferential effect of eccentric exercise in this tissue (subsequent to time and 
chronic repetition). Given time and continuation of the aggravating activity, clinical tendon pain may 
result. Potential treatments may include eccentric training to condition the muscle not to become disrupted 
at the level of the sarcomere in subsequent bouts of eccentric activity thereby protecting the connective 
tissue and tendon. Pain management strategies in future may look to the targeting of specific peripheral 
receptors such as NMDA and TRPV1 if future research confirms they do play a role in clinical tendon pain. 
Referred pain/widespread pain and central sensitisation may be closely related in patients who have 
chronic pain. Methods of allaying or avoiding this central sensitisation facilitation of referred pain may be 
necessary to treat the widespread pain commonly seen in chronic pain patients. 
 
Future perspectives 
This series of studies has elucidated some of the pain mechanisms behind fascial and 
tendon pain. The next step is to investigate the interaction between experimental tendon 
pain and motor control. Many common musculoskeletal complaints display alterations in 
motor control of surrounding musculature compared to healthy subjects: patellofemoral 
pain (Cowan et al. 2001), groin pain (Cowan et al. 2004) and low back pain (O'Sullivan 
et al. 1997) being just a few examples. There is however, no current information 
regarding tendinopathy and motor control. It is very important to investigate this as 
physiotherapists routinely prescribe strength training for tendinopathy patients and it is 
important to know what the motor effect of pain in these structures is. Additionally it 
would be very interesting to know if, and to what extent these possible motor control 
deficits during tendon pain can be reversed by removal of the pain. It may be that motor 
control alterations are immediately reversible following pain cessation or they may 
persist and require prolonged re-training. At present this is unknown and deserves to be 
investigated. 
 
Eccentric exercise appears to be a key factor in tendinopathy. It has also become a 
mainstay of conservative treatment for tendinopathy and does seem to relieve pain 
although it is yet unknown as to how the pain reduction occurs. A mechanical effect on 
the neovessels (strongly associated with tendon pain) by the ongoing eccentric exercise 
has been proposed (Alfredson and Lorentzon 2003) but this seems unconvincing given 
how frequently eccentric activity occurs in everyday life without any apparent effect on 
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tendinopathic neovessels. Flowing from this current series of studies is the proposal that 
connective tissue is sensitised following eccentric exercise and that it is therefore exposed 
to excessive stress during eccentric exercise. It is worth investigating if the conservative 
eccentric training programmes simply allow the muscle to adapt to eccentric stresses by 
sarcomerogenesis with subsequent greater ability to maintain contractile efficiency 
during eccentric activity, thus affording connective tissue some degree of  ‘stress 
shielding’ and healing in the tendon to occur.  
 
Lastly, the effect of peripheral NMDA and TRPV1 receptor antagonists should be 
assessed in clinical tendon pain patients. If this can reduce perceived pain or 
mechanosensitivity in tendinopathic patients then further investigation of modulatory 
action between the two receptor types may be worth exploring as an avenue of future 
clinical pain management strategies for these patients. 
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Dansk sammenfatning 
I dette Ph.D.-studie undersøges de sensoriske symptomer relateret til eksperimentel 
smerte for sene-, fascial og muskelvæv. Det er blevet fastslået, at følsomheden overfor 
hyperton saltvandsopløsning er større i senevævsstrukturer end i muskelvæv (studie I, II 
og III). Dette er klinisk relevant, da det tyder på, at bidraget fra senevævs- og 
fascialstrukturer til den klinisk udbredte term ”muskelsmerte” bør undersøges grundigt. 
Forøget mekanisk følsomhed i senevæv ved eksperimentel smerte (saltvandsopløsning, 
glutamin og capsaicin) er muligvis ikke resultatet af periferisk følsomhed (studie I og IV), 
men i stedet kan der forekomme en central summering mellem den påførte smerte og de 
mekaniske stimuli, der fører til en lavere mekanisk smertetærskel. Dette kan være vigtigt, 
da kroniske smertepatienter sandsynligvis er disponeret for at udvise en central 
smertefølsomhed overfor smertebehandlingsmekanismer, og derfor bliver den normale 
mekaniske følsomhed under disse forhold som regel stærkt påvirket af de centrale 
mekanismer. Samtidig kan der konstateres en manglende inflammatorisk proces i disse 
patienter (med mulig efterfølgende mangel på de periferiske følsomhedsstoffer), og 
derfor bør den centrale mekanisme for mekanisk følsomhed undersøges nærmere i 
fremtidige smertestyringsstrategier. Senestrukturer i sig selv er muligvis ikke følsomme 
overfor akut induktion af DOS (studie III). Derimod er det blevet demonstreret, at 
seneforbindende væv viser en forøget følsomhed under sensitive forhold af DOS og må 
derfor betragtes som stedet, hvor DOS-effekten viser sig ved gentagne excentriske 
øvelser. Dette kan give et indblik i den ødelæggende effekt ved gentagne excentriske 
øvelser, der kan betyde, at det forbindende væv må være udsat for et unormalt stort 
stressniveau under kontraktion, (hvilket bevirker, at det bliver sensitivt), når de 
myofibrillare kontraktionsmekanismer bliver ineffektive. Desuden er refereret smerte ofte 
mere anerkendt for DOS-konditioner (sammenlignet med før DOS) i relation til stimuli af 
tilsvarende smerteintensitet som den før-DOS-inducerede (studie II). Slutteligt er det 
påvist, at funktionelt glutamin og TRPV1-receptorer er funktionsdygtige i senevæv 
(studie IV), og der forekommer reaktionsmoduleringer mellem disse receptortyper. 
Derfor bør disse receptorer undersøges i klinisk senevævssmerte.  På nuværende 
tidspunkt er det ikke påvist, (men det er bestemt værd at undersøge), om 
aktivitetsmodulation i begge disse receptortyper kan opnås ved udvikling af antagonister 
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rettet mod NMDA-receptorer i kliniske situationer. Denne Ph.D. afhandling belyser nogle 
af de mekanismer og karakteristika for smerte i menneskets sene-, fascial- og muskelvæv. 
Resultaterne har speciel betydning for behandling og mulig forebyggelse af 
senevævssmerter. 
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Appendix 1:  
 
Review of research papers investigating mechanosensitivity and referred pain patterns in 
muscle, ligament, joint/joint associated structures and tendon/fascia following injection 
of hypertonic saline. All mechanosensitivity tests were assessed in the vicinity of the 
injection site and all were assessed during pain. 
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Table 1 
Tissue investigated Reference(s) Local mechanical 
sensitivity during 
pain 
Referred pain 
established 
Muscle: Temporalis, 
tibialis anterior, 
trapezius, extensor carpi 
radialis brevis, triceps 
surae. Generally placebo 
controlled except (*) 
Jensen and Norup 
(1992); Graven-
Nielsen et al. (1998); 
Graven-Nielsen et 
al.(1998a); Ge et al. 
(2003); Graven-
Nielsen et al. (2003); 
Slater et al. (2003); 
Weerakkody et al. 
(2003)* 
Quantitative testing 
supplying ambiguous 
results: Hyperalgesic 
(Jensen and Norup, 
Graven-Nielsen et al. 
1998), hypoalgesic 
(Slater et al.) and 
unchanged (Graven-
Nielsen et al. 1998a, 
Ge et al.,  
Weerakkody et al.) 
sensitivity reported. 
Consistent and well 
defined referred 
pain patterns 
described during 
experimental 
muscle pain. 
Joint and associated 
structures: Knee joint, 
Acromioclavicular joint, 
subacromial space, 
sternoclavicular joint, 
infrapatellar fat pad. No 
placebo control 
Steinbrocker et al. 
(1953);Gerber et al. 
(1998);Hassett and 
Barnsley 
(2001);Bennell et al. 
(2004). 
No deep tissue 
quantitative 
assessment. Bennell et 
al. utilized Von Frey 
filaments to assess 
superficial sensibility 
(no change). Gerber et 
al. and Steinbrocker et 
al. reported subjective 
‘tenderness’ during 
pain. 
Referred pain 
frequently seen 
following 
experimental 
painful stimulation 
of joint. 
Tendon and fascia 
(references marked with 
‘*’ investigated both 
tendon and fascia): 
Tibialis anterior, biceps 
distal tendon, tendo-
Achilles, common 
forearm extensor tendon 
origin (CEO). No placebo 
control 
Kellgren (1938)*; 
Inman and Saunders 
(1944)*; 
Steinbrocker et al. 
(1953); Slater et al. 
(2003). 
Slater et al. found no 
change in sensitivity 
at common extensor 
tendon without 
placebo trial. All 
others did not supply 
quantitative data. 
Ambiguous results 
for tendon: local 
(Kellgren, 
Steinbrocker et al.) 
and referred (Slater 
et al.) pain patterns 
reported. Fascia 
described as 
producing 
predominantly local 
pain. 
Ligament: Cervical, 
thoracic and lumbar 
interspinous ligaments. 
No placebo control. 
Kellgren (1939); 
Lewis and Kellgren 
(1939); Inman and 
Saunders (1944); 
Sinclair et al.(1948); 
Hockaday and 
Whitty (1967). 
No quantitative data. 
Varying reports of 
subjective 
‘hyperalgesia’ locally 
and distant. 
Well defined 
reproducible pain 
reproduction from 
interspinous 
ligaments. 
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